Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials

OBJECTIVE: We conducted a post hoc analysis of two randomized controlled trials, GWPCARE1 (NCT02091375) and GWPCARE2 (NCT02224703), to estimate the time to onset of cannabidiol (CBD) treatment effects (seizure reduction and adverse events [AEs]) in patients with Dravet syndrome (DS). METHODS: Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Madan Cohen, Jennifer, Checketts, Daniel, Dunayevich, Eduardo, Gunning, Boudewijn, Hyslop, Ann, Madhavan, Deepak, Villanueva, Vicente, Zolnowska, Marta, Zuberi, Sameer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456817/
https://www.ncbi.nlm.nih.gov/pubmed/34265088
http://dx.doi.org/10.1111/epi.16974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456817/
https://www.ncbi.nlm.nih.gov/pubmed/34265088
http://dx.doi.org/10.1111/epi.16974

Ejemplares similares